Tocagen

Hard knocks for brain cancer, again

In the wake of two phase III glioblastoma failures this month, from Abbvie and Bristol-Myers Squibb, hopes dim for another big readout from Tocagen.

Upcoming events – crucial cancer data for Tocagen and Syndax

Tocagen could soar or sink on interim brain cancer data, while judgement day approaches for Syndax.

June 29, 2018

Upcoming events – Tocagen’s brain cancer data and Restorbio tackles respiratory infections

Mid-stage data for Tocagen and Restorbio are approaching.

March 12, 2018

Therapy focus: no giving up on brain cancer

July 05, 2017

Biotech floats come back with a vengeance

The biotech IPO market records its first billion dollar quarter in two years as demand for new issues recovers.

October 07, 2016

Lively M&A scene keeps biotech shares buoyant in Q3

July 07, 2016

Genmab and Tesaro lead first-half gainers as Endo and Infinity falter

June 22, 2016

Interview – Tocagen touts two-step cancer vaccine

August 17, 2012

Therapeutic Focus – Avastin provides glimmer in glioblastoma but progress still slow